PE20121685A1 - Antigeno ndv recombinante y usos del mismo - Google Patents
Antigeno ndv recombinante y usos del mismoInfo
- Publication number
- PE20121685A1 PE20121685A1 PE2012000888A PE2012000888A PE20121685A1 PE 20121685 A1 PE20121685 A1 PE 20121685A1 PE 2012000888 A PE2012000888 A PE 2012000888A PE 2012000888 A PE2012000888 A PE 2012000888A PE 20121685 A1 PE20121685 A1 PE 20121685A1
- Authority
- PE
- Peru
- Prior art keywords
- ndv
- antigen
- same
- polypeptide
- variety
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 241000711404 Avian avulavirus 1 Species 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000009851 immunogenic response Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/517—Plant cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
SE REFIERE A UNA COMPOSICION QUE COMPRENDE UN POLIPEPTIDO O ANTIGENO HN (HEMAGLUTININA-NEURAMINIDASA) DEL NDV (VIRUS DE LA ENFERMEDAD DE NEWCASTLE) Y UN TRANSPORTADOR, EXCIPIENTE, VEHICULO O ADYUVANTE FARMACEUTICAMENTE ACEPTABLE O APTO PARA USO VETERINARIO TAL COMO UNA EMULSION DE AGUA EN ACEITE O DE ACEITE EN AGUA. DICHO POLIPEPTIDO O ANTIGENO HN NDV TIENE AL MENOS UN 80% DE IDENTIDAD DE SECUENCIA CON LA SECUENCIA SEQ ID Nº: 3, 5, 7, 9, 15, 17 O 20, ADEMAS COMPRENDE UN FRAGMENTO INMUNOGENICO QUE COMPRENDE UNA REGION DEL EPITOPE LINEAL HN NDV. REFERIDO ADEMAS A UN METODO DE PRODUCCION. DICHA COMPOSICION GENERA UNA RESPUESTA INMUNOGENICA EN UN ANIMAL
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29029709P | 2009-12-28 | 2009-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20121685A1 true PE20121685A1 (es) | 2012-12-28 |
Family
ID=44189168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2012000888A PE20121685A1 (es) | 2009-12-28 | 2010-12-28 | Antigeno ndv recombinante y usos del mismo |
Country Status (11)
Country | Link |
---|---|
US (1) | US10633667B2 (es) |
EP (2) | EP2519258B1 (es) |
JP (1) | JP5933451B2 (es) |
KR (1) | KR20120101572A (es) |
CN (1) | CN103260643A (es) |
AR (2) | AR079767A1 (es) |
CA (1) | CA2785653C (es) |
DO (1) | DOP2012000187A (es) |
MX (1) | MX351643B (es) |
PE (1) | PE20121685A1 (es) |
WO (1) | WO2011090708A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4130273A1 (en) * | 2009-12-28 | 2023-02-08 | Sanofi Vaccine Technologies, S.A.S. | Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof |
EA030095B1 (ru) * | 2009-12-28 | 2018-06-29 | ДиЭсЭм АйПи АССЕТС Б.В. | Получение белка гемагглютинин-нейраминидазы в микроводорослях |
WO2012153160A1 (es) * | 2011-05-07 | 2012-11-15 | Laboratorio Avi-Mex, S.A. De C.V. | Vacuna recombinante contra prrs en vector viral |
US9358283B2 (en) | 2011-10-28 | 2016-06-07 | The Regents Of The University Of California | Diatom-based vaccines |
WO2013164095A1 (en) * | 2012-05-02 | 2013-11-07 | Algenics | Production of secreted therapeutic antibodies in microalgae |
EP2660324A1 (en) * | 2012-05-02 | 2013-11-06 | Algenics | Production of secreted therapeutic antibodies in microalgae |
EP2660323A1 (en) * | 2012-05-02 | 2013-11-06 | Algenics | Production of secreted therapeutic antibodies in phaeodactylum tricornutum microalgae |
EP2671950A1 (de) * | 2012-06-06 | 2013-12-11 | Philipps-Universität Marburg | Expression und Sekretion von rekombinanten, vollständig assemblierten Proteinkomplexen durch Mikroalgen |
CN105695491B (zh) * | 2014-05-09 | 2020-01-10 | 中国农业科学院生物技术研究所 | 鸡新城疫糖蛋白病毒抗原的制备方法及其产品 |
CN105567715B (zh) * | 2014-10-17 | 2021-06-29 | 丰益(上海)生物技术研发中心有限公司 | 裂殖壶菌α-微管蛋白相关序列及其应用 |
AU2015342997B2 (en) * | 2014-11-05 | 2021-11-18 | Research Institute At Nationwide Children's Hospital | Methods and materials for producing recombinant viruses in eukaryotic microalgae |
US10196616B2 (en) * | 2017-02-15 | 2019-02-05 | The United States Of America, As Represented By The Secretary Of Agriculture | Altered avian virus for in-ovo inoculation and methods of use thereof |
CN107099513B (zh) * | 2017-06-22 | 2020-07-14 | 北京邦卓生物科技有限公司 | 一种共表达ndv hn和ibdv vp2基因的hvt的构建及其应用 |
CN113652406B (zh) * | 2021-09-01 | 2023-05-02 | 青岛易邦生物工程有限公司 | 一种鸡传染性喉气管炎重组病毒株及其应用 |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
US4708871A (en) | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
US5380831A (en) | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
US4761373A (en) | 1984-03-06 | 1988-08-02 | Molecular Genetics, Inc. | Herbicide resistance in plants |
EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
JPH0795952B2 (ja) | 1986-01-08 | 1995-10-18 | カルジ−ン・インコ−ポレイテツド | ハロアリ−ルニトリル分解遺伝子、その使用および該遺伝子含有細胞 |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
US5990387A (en) | 1988-06-10 | 1999-11-23 | Pioneer Hi-Bred International, Inc. | Stable transformation of plant cells |
NZ230375A (en) | 1988-09-09 | 1991-07-26 | Lubrizol Genetics Inc | Synthetic gene encoding b. thuringiensis insecticidal protein |
BR9007159A (pt) | 1989-02-24 | 1991-12-10 | Monsanto Co | Genes sinteticos de plantas e processo para a preparacao dos mesmos |
US5879918A (en) | 1989-05-12 | 1999-03-09 | Pioneer Hi-Bred International, Inc. | Pretreatment of microprojectiles prior to using in a particle gun |
US5202422A (en) | 1989-10-27 | 1993-04-13 | The Scripps Research Institute | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
AU651101B2 (en) | 1990-04-18 | 1994-07-14 | Plant Genetic Systems N.V. | Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells |
US5932782A (en) | 1990-11-14 | 1999-08-03 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species adhered to microprojectiles |
US6309647B1 (en) | 1999-07-15 | 2001-10-30 | Aventis Pasteur | Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants |
US5863542A (en) | 1991-03-07 | 1999-01-26 | Virogenetics Corporation | Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts |
KR100242671B1 (ko) | 1991-03-07 | 2000-03-02 | 고돈 에릭 | 유전학적으로 처리한 백신 균주 |
TW261517B (es) | 1991-11-29 | 1995-11-01 | Mitsubishi Shozi Kk | |
CA2140910C (en) | 1992-07-27 | 1999-03-23 | Jeffrey A. Townsend | An improved method of agrobacterium-mediated transformation of cultured soybean cells |
DE69434624T2 (de) | 1993-11-19 | 2006-12-14 | Biotechnology Research And Development Corp., Peoria | Chimäre regulatorische regionen und gen - kassetten zur genexpression in pflanzen |
EP0826063A1 (en) | 1995-04-25 | 1998-03-04 | Vical Incorporated | Single-vial formulations of dna/lipid complexes |
AU6504796A (en) | 1995-07-20 | 1997-02-18 | Washington State University Research Foundation | Production of secreted foreign polypeptides in plant cell culture |
US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
FR2750866B1 (fr) | 1996-06-27 | 1998-11-27 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
FR2751224B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
FR2751227B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
FR2751228B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
FR2751225B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
FR2751229B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
ES2241042T3 (es) | 1996-10-11 | 2005-10-16 | The Regents Of The University Of California | Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora. |
US5981840A (en) | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
FR2758986B1 (fr) | 1997-01-31 | 1999-04-30 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
CN1261807A (zh) | 1997-06-30 | 2000-08-02 | 罗纳-布朗克罗莱尔股份有限公司 | 向横纹肌中转移核酸的改进方法和用于实施该方法的组合 |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
US7161064B2 (en) * | 1997-08-12 | 2007-01-09 | North Carolina State University | Method for producing stably transformed duckweed using microprojectile bombardment |
FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
US8003772B2 (en) | 1999-01-14 | 2011-08-23 | Martek Biosciences Corporation | Chimeric PUFA polyketide synthase systems and uses thereof |
FR2801607B1 (fr) | 1999-11-26 | 2001-12-28 | Merial Sas | Pneumovirus du canard et vaccins correspondants |
US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
EP1305437B1 (en) | 2000-07-31 | 2010-09-01 | Biolex Therapeutics, Inc. | Expression of biologically active polypeptides in duckweed |
AU2002224815B2 (en) | 2000-11-02 | 2006-10-12 | Intervet International B.V. | A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
TWI377253B (en) | 2001-04-16 | 2012-11-21 | Martek Biosciences Corp | Product and process for transformation of thraustochytriales microorganisms |
NZ529762A (en) | 2001-05-30 | 2006-02-24 | Biolex Inc | Use of duckweed in high throughput screening |
CA2491568A1 (en) * | 2002-08-27 | 2004-03-11 | Dow Agrosciences Llc | Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
WO2004098533A2 (en) | 2003-05-05 | 2004-11-18 | Boyce Thompson Institute For Plant Research | Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
US20040268442A1 (en) * | 2003-05-05 | 2004-12-30 | Dow Agrosciences Llc | Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
US7371395B2 (en) | 2003-07-24 | 2008-05-13 | Merial Limited | Vaccine formulations |
US8936930B2 (en) * | 2004-08-05 | 2015-01-20 | Ben-Gurion University Of The Negev Research And Development Authority | Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same |
JP4796787B2 (ja) | 2005-04-28 | 2011-10-19 | 富士フイルム株式会社 | ラビリンチュラ類への遺伝子導入法 |
JP4796786B2 (ja) * | 2005-04-28 | 2011-10-19 | 富士フイルム株式会社 | ラビリンチュラ類を形質転換可能なベクター |
US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
US9216212B2 (en) * | 2005-08-05 | 2015-12-22 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
EP2238253B1 (en) | 2007-11-27 | 2012-09-12 | Medicago Inc. | Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
EP2090648A1 (en) * | 2008-02-12 | 2009-08-19 | Institut Francais de Recherche pour l'Exploitation de la Mere(Ifremer) | Production of glycosylated polypeptides in microalgae |
US7794714B2 (en) | 2008-03-14 | 2010-09-14 | The United States Of America As Represented By The Secretary Of Agriculture | Newcastle disease virus monoclonal antibodies |
EP2367566B2 (en) * | 2008-11-28 | 2019-11-27 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant avian influenza vaccine and uses thereof |
EA030095B1 (ru) * | 2009-12-28 | 2018-06-29 | ДиЭсЭм АйПи АССЕТС Б.В. | Получение белка гемагглютинин-нейраминидазы в микроводорослях |
EP4130273A1 (en) * | 2009-12-28 | 2023-02-08 | Sanofi Vaccine Technologies, S.A.S. | Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof |
-
2010
- 2010-12-28 JP JP2012546255A patent/JP5933451B2/ja active Active
- 2010-12-28 EP EP10844257.5A patent/EP2519258B1/en active Active
- 2010-12-28 AR ARP100104979A patent/AR079767A1/es not_active Application Discontinuation
- 2010-12-28 WO PCT/US2010/062209 patent/WO2011090708A2/en active Application Filing
- 2010-12-28 EP EP17153588.3A patent/EP3213766A1/en not_active Withdrawn
- 2010-12-28 MX MX2012007545A patent/MX351643B/es active IP Right Grant
- 2010-12-28 CA CA2785653A patent/CA2785653C/en active Active
- 2010-12-28 KR KR1020127020029A patent/KR20120101572A/ko not_active Application Discontinuation
- 2010-12-28 CN CN2010800634100A patent/CN103260643A/zh active Pending
- 2010-12-28 US US12/979,677 patent/US10633667B2/en active Active
- 2010-12-28 PE PE2012000888A patent/PE20121685A1/es not_active Application Discontinuation
-
2012
- 2012-06-27 DO DO2012000187A patent/DOP2012000187A/es unknown
-
2020
- 2020-10-19 AR ARP200102888A patent/AR122325A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2785653A1 (en) | 2011-07-28 |
EP2519258B1 (en) | 2017-07-26 |
DOP2012000187A (es) | 2012-12-15 |
EP3213766A1 (en) | 2017-09-06 |
AR122325A2 (es) | 2022-08-31 |
US10633667B2 (en) | 2020-04-28 |
JP2013515747A (ja) | 2013-05-09 |
AR079767A1 (es) | 2012-02-15 |
JP5933451B2 (ja) | 2016-06-08 |
CA2785653C (en) | 2018-05-01 |
EP2519258A2 (en) | 2012-11-07 |
MX351643B (es) | 2017-10-23 |
WO2011090708A2 (en) | 2011-07-28 |
MX2012007545A (es) | 2012-11-12 |
WO2011090708A3 (en) | 2011-12-15 |
US20110162115A1 (en) | 2011-06-30 |
KR20120101572A (ko) | 2012-09-13 |
CN103260643A (zh) | 2013-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20121685A1 (es) | Antigeno ndv recombinante y usos del mismo | |
CO2018005229A2 (es) | Vacuna de virus sincitial respiratorio | |
RU2015132962A (ru) | Иммуногенные композиции на основе вируса гриппа и их применение | |
ES2541217T3 (es) | Diferenciación de células madre mesenquimales | |
DK1968632T3 (da) | Forbedret influenzavaccine | |
ES2663872T3 (es) | Composición inmunogénica o vacuna contra infección o enfermedad bacteriana gramnegativa, por ejemplo, por Neisseria | |
CL2018000232A1 (es) | Mezcla de péptidos (divisional solicitud 201601405) | |
AR064642A1 (es) | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi | |
AR061894A1 (es) | Vacunas para malaria | |
AR092712A1 (es) | Una proteina con actividad cetosa 3-epimerasa | |
ES2627330T3 (es) | Uso de JAZ5a para mejorar la resistencia a la sequía en una planta | |
ES2531115T3 (es) | Combinaciones de clados de RrgB neumocócicos | |
CO6210756A2 (es) | La proteina linfopoyetina estromal timica canina y usos de la misma | |
CL2011001993A1 (es) | Composicion inmunogenica que comprende al menos un antigeno del virus del dengue inactivado y un adyuvante sin aluminio; metodo de produccion; y su uso para prevenir, mejorar o tratar una enfermedad productiva por el virus del dengue en un sujeto. | |
PL396415A1 (pl) | Szczepionka DNA, sposób indukowania odpowiedzi immunologicznej, przeciwciala specyficznie rozpoznajace bialko hemaglutyniny H5 wirusa grypy i zastosowanie szczepionki DNA | |
AR087749A1 (es) | Anticuerpos anti-xcr1 humano | |
CO2017011431A2 (es) | Proteínas de fusión de receptor de factor de crecimiento epidermal variante iii - mesotelina | |
BR112016016103A2 (pt) | Composição de antígenos micobacterianos | |
EA201500140A1 (ru) | Ослабленные вакцины от свиного гриппа и способы их получения и применения | |
AR051853A1 (es) | Vacuna para aumentar el crecimiento basada en epitopes neutralizantes | |
AR100824A1 (es) | Complejo de poliproteínas inmunogénicas de m. hyopneumoniae, gen sintético codificante del complejo de proliproteínas inmunogénicas de m. hyopneumoniae, composición antigénica, proceso de obtención de un complejo de poliproteínas inmunogénicas de m. hyopneumoniae, uso de una composición con base en el complejo de poliproteínas inmunogénicas de m. hyopneumoniae | |
CL2020002373A1 (es) | Composición de vacuna que comprende un péptido aislado de piojo de mar; uso de la vacuna para para prevenir o controlar una infestación de piojos de mar en un salmónido; vector; célula hospedadora (divisional de la solicitud no. 201900422). | |
AR074273A1 (es) | Composicion inmunigenica de multiples componentes para la prevencion de la enfermedad estreptococica beta-hemolitica bhs. uso. metodo | |
AR072156A1 (es) | Proteinas de fusion y su aplicacion para la preparacion de vacunas contra la hepatitis c y b | |
BR112015023738A2 (pt) | vacinas de nucleoproteina influenza |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |